Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.
J Nanobiotechnology. 2022 Jan 25;20(1):50. doi: 10.1186/s12951-022-01264-5.
J Nanobiotechnology. 2022.
PMID: 35078498
Free PMC article.
The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K, Jiao J, Xu C, Dong Y, Li D, He D, Zhao D, Yu J, Sun Y, Zhang W, Bai M, Duan Y.
Gong K, et al.
J Nanobiotechnology. 2021 May 31;19(1):165. doi: 10.1186/s12951-021-00904-6.
J Nanobiotechnology. 2021.
PMID: 34059068
Free PMC article.
Item in Clipboard
A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer.
Chen C, Shen M, Liao H, Guo Q, Fu H, Yu J, Duan Y.
Chen C, et al.
J Nanobiotechnology. 2021 Feb 25;19(1):55. doi: 10.1186/s12951-021-00800-z.
J Nanobiotechnology. 2021.
PMID: 33632232
Free PMC article.
Item in Clipboard
Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.
Dong Y, Liao H, Yu J, Fu H, Zhao D, Gong K, Wang Q, Duan Y.
Dong Y, et al.
J Nanobiotechnology. 2019 Dec 23;17(1):125. doi: 10.1186/s12951-019-0559-y.
J Nanobiotechnology. 2019.
PMID: 31870362
Free PMC article.
Item in Clipboard
Cite
Cite